CPT code 11624 denotes the surgical excision of a malignant skin lesion with margins for lesions measuring 3.1 to 4.0 cm in diameter, performed on anatomically sensitive areas such as the scalp, neck, hands, feet, or genitalia. This code is a key surgical oncology CPT descriptor used nationwide for reporting and payment of wide local excisions of skin cancers in high-complexity anatomical sites. Accurate use of this code affects clinical documentation, billing integrity, and aggregate national procedure counts for dermatologic and surgical oncology care.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks for typical reimbursement and utilization patterns, coding guidance context, and clinical considerations tied to lesion size and anatomic location. The content also summarizes common modifiers in use and notes where additional coding detail or documentation is frequently required.

This publication provides a concise reference to the clinical scope of CPT code 11624, its role in surgical dermatology and oncology practice, and the payer landscape that influences coding and billing. Data not available in the input are noted where applicable.